Device Trial Radar · NCT06078865
FX Shoulder Prospective Clinical Study
Last checked: Nov 20, 2026Latest source record: Feb 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
600
Planned (sponsor's estimate)
Start
Mar 31, 2021
Primary completion
Dec 30, 2031
Study completion Dec 30, 2031
Sponsor
- Lead sponsor
- FX Shoulder SolutionsNot on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 12, 2023
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Prospective Multi-Center Registry on study subjects with implanted devices marketed and legally commercialized in the USA by FX Shoulder Solutions.
Conditions
- Osteoarthritis Shoulder
- Rotator Cuff Syndrome of Shoulder and Allied Disorders
- Fracture, Shoulder
Interventions
FX Artificial Shoulder ProsthesisDevice
Humelock II Anatomic Shoulder System, Humelock II Reversible Shoulder System, Humelock Reverse Shoulder System, Humeris Shoulder System, Easytech Anatomical Shoulder System, FXV135 Mini Shoulder System, FXV135 Humelock Shoulder System
Primary outcomes
What the sponsor says the trial is designed to measure.
- A patient is considered a success at post-operative follow-up based upon the following composite clinical success (CCS):Time frame: 2 years
1 more outcomes with a free account
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
OrthoArizona
Gilbert, Arizona · Recruiting
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.